Antihypertensive Therapy with Once‐daily Administration of Terazosin, a New Alpha1‐adrenergic‐receptor Blocker

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

Volumn 5, Issue 5, 1985, Pages 285-289

  Abraham, Paul A ^a   Halstenson, Charles E ^a   Matzke, Gary R ^a   Napier, Jerold L ^a   Keane, William F ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; TERAZOSIN;

ADVERSE DRUG REACTION; BLOOD PRESSURE; BODY WEIGHT; CARDIOVASCULAR SYSTEM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DIGESTIVE SYSTEM; DRUG DOSE; DRUG EFFICACY; DRUG THERAPY; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL TOXICITY; HEADACHE; HOT FLUSH; HUMAN; HYPERTENSION; INSOMNIA; INTOXICATION; LIPID BLOOD LEVEL; MYALGIA; NERVOUS SYSTEM; NEUROTOXICITY; NOSE CONGESTION; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; THERAPY; TOOTH; TOOTH PAIN; TREMOR; VERTIGO;

EID: 0022341052     PISSN: 02770008     EISSN: 18759114     Source Type: Journal    
DOI: 10.1002/j.1875-9114.1985.tb03429.x     Document Type: Article

References (17)

1. Alpha‐adrenergic‐blocking properties of terazosin
2. Effect of terazosin on blood pressure and lipids in hypertension
3. Terazosin: safety and efficacy in essential hypertension, and effects on serum lipids
4. Estimation of the concentration of low‐density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
5. Response to placebo treatment in hypertension
6. Does placebo lower blood‐pressure?
7. Physiologic mechanisms opposing the hemodynamic effects of prazosin
8. The relationship of salt intake and the renin‐angiotensin system to the first‐dose prazosin response
9. α‐Receptor function changes after the first dose of prazosin
10. Selective alpha,‐adrenergic antagonists: therapeutically relevant antihypertensive agents
11. Long‐term BP monitoring in the evaluation of antihypertensive therapy
12. Physiologic evaluation of a new antihypertensive agent: prazosin HCI
13. Effects of prazosin therapy on BP, renal function, and body fluid composition
14. A vasodilator that avoids renin stimulation and fluid retention: antihypertensive treatment with trimazosin
15. Summary of prazosin lipid studies
16. Proceedings of a symposium. Initial therapy in hypertension
17. Proceedings of a symposium. First‐line therapy for hypertension: changing directions